Bio/Pharmaceutical Product Launch and Commercialization

Pharmaceutical Product Launch and Commercialization

The evolving health care landscape has imminent impact on pharmaceutical product launches. While evidence generation impacts the product development, launch strategies are impacted due to access, payment innovations, delivery reform, and limitations in customer engagement. This Summit examines critical elements for an effective go-to-market strategy for product launch and immediate post-launch activities while depicting ways to overcome hidden obstacles and strategies for success.

Faculty Interview

	Gary C. Cupit, PharmD CEO and Director Somnus Therapeutics, Inc
With over 20 years of experience in the drug industry including several product launches, Gary Cupit knows what it takes to succeed in the "new normal" global pharmaceutical landscape. The pressure is only likely to increase with patents expiring and product pipelines shrinking. How will increasing data collection help?
Listen Now!

Key Takeaways:

• Analyze, forecast, and predict lifecycle success
• Set an accurate and achievable launch date through efficient timeline planning
• Optimize the roles of HEOR, Pricing, Sales, and Medical Affairs for commercial success
• Leverage social media strategies and tools to engage patient populations, build brand reputation, and support new products
• Determine optimal opportunities for Joint Venture and Alliance partnering